Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies.

导出 OA

翻译打印收藏纠错

第一作者： Maria,Fleseriu

第一单位： Departments of Medicine and Neurological Surgery, and Northwest Pituitary Center, Oregon Health & Science University, Mail Code: CH8N, 3303 SW Bond Ave, Portland, OR, 97239, USA. fleseriu@ohsu.edu.

作者： Maria,Fleseriu ^[1] ; Frederic,Castinetti ^[2]

作者单位： Departments of Medicine and Neurological Surgery, and Northwest Pituitary Center, Oregon Health & Science University, Mail Code: CH8N, 3303 SW Bond Ave, Portland, OR, 97239, USA. fleseriu@ohsu.edu. ^[1] Aix Marseille University, CNRS, CRN2M, Department of Endocrinology, Assistance Publique Hopitaux de Marseille, Marseille, France. ^[2]

关键词 Adrenal steroidogenesis inhibitor Cushing’s disease Cushing’s syndrome Ketoconazole LCI699 Levoketoconazole Metyrapone Osilodrostat

主题词库欣综合征(Cushing Syndrome);人类(Humans)

DOI 10.1007/s11102-016-0742-1

PMID 27600150

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交